(Q45964649)

18 December 2017

title

Hyperglycemic kidney damage in an animal model of prolonged critical illness. (English)

1 reference

18 December 2017

1 reference

1 reference

1

1 reference

18 December 2017

Greet Van den Berghe

10

1 reference

18 December 2017

Jan Gunst

object named as

Jan Gunst

2

0 references

Paul J Thornalley

object named as

Paul J Thornalley

8

0 references

author name string

Björn Ellger

3

1 reference

18 December 2017

Magaly Boussemaere

4

1 reference

18 December 2017

Evelyne Lerut

5

1 reference

18 December 2017

Yves Debaveye

6

1 reference

18 December 2017

Naila Rabbani

7

1 reference

18 December 2017

Miet Schetz

9

1 reference

18 December 2017

language of work or name

English

0 references

publication date

17 June 2009

1 reference

18 December 2017

published in

Kidney International

1 reference

18 December 2017

volume

76

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

512-520

1 reference

18 December 2017

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Risk factors for acute renal failure: inherent and modifiable risks.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy in the medical ICU.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Tight blood glucose control is renoprotective in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Tight blood glucose control with insulin in the ICU: facts and controversies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Effect of an intensive glucose management protocol on the mortality of critically ill adult patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy and mortality in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive versus conventional glucose control in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Glucose control in the ICU--how tight is too tight?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy in the intensive care unit

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Intensive insulin therapy protects the endothelium of critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Survival Benefits of Intensive Insulin Therapy in Critical Illness: Impact of Maintaining Normoglycemia Versus Glycemia-Independent Actions of Insulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Energy and nitrogen metabolism of rabbits during pregnancy, lactation, and concurrent pregnancy and lactation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Update on mechanisms of ischemic acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Renal oxygen delivery: matching delivery to metabolic demand

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Mitochondrial dysfunction in sepsis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Ileal VO(2)-O(2) alterations induced by endotoxin correlate with severity of mitochondrial injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Association between mitochondrial dysfunction and severity and outcome of septic shock

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Dicarbonyl intermediates in the maillard reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Toxicity of glyoxals--role of oxidative stress, metabolic detoxification and thiamine deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

The cytotoxic mechanism of glyoxal involves oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Modification of the glyoxalase system in human red blood cells by glucose in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Lactate and glucose metabolism in severe sepsis and cardiogenic shock

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

A global approach to energy metabolism in an experimental model of sepsis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Effect of Intensive Insulin Therapy on Insulin Sensitivity in the Critically Ill

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

48 Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Sample Storage Conditions for the Assay of Glyoxalase Activities in Whole Blood Samples

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.217

7 January 2021

Identifiers

DOI

10.1038/KI.2009.217

1 reference

18 December 2017

Dimensions Publication ID

1027066520

0 references

1 reference

18 December 2017